Skip to main content
. 2022 Jan 25;13(2):216. doi: 10.3390/genes13020216

Figure 10.

Figure 10

Immunotherapy and drug sensitivity prediction. (a,b) T cell dysfunction and T cell exclusion in the high– and low–risk patients with TCGA-UCEC. (cj) Wilcoxon rank sum test was applied for comparing the different chemotherapeutic response predictions in high– and low–risk patients. *** equals p < 0.001.